Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
SAAKSHI

Saakshi Medtech & Panels Share Price

 

 

Saakshi Medtech & Panels live price: ₹236. It opened at ₹231 vs previous close ₹236; intraday high/low: ₹245/₹231. The 50 & 200 DMA stand at ₹219.23/₹194.94.

Saakshi Medtech & Panels Performance

  • Today's Low
  • ₹231
  • Today's High
  • ₹245
  • 52 Week Low
  • ₹133
  • 52 Week High
  • ₹276
  • Open Price₹231
  • Previous Close₹236
  • Volume5,400
  • 50 DMA₹219.23
  • 100 DMA₹205.56
  • 200 DMA₹194.94

Saakshi Medtech & Panels Chart

Investment Returns

  • Over 1 Month + 2.03%
  • Over 3 Month + 30.39%
  • Over 6 Month + 29.71%
  • Over 1 Year + 69.6%

Smart Investing Starts Here Start SIP with Saakshi Medtech & Panels for Steady Growth!

Invest Now

Saakshi Medtech & Panels Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 33.9
  • PEG Ratio
  • -
  • Market Cap Cr
  • 417
  • P/B Ratio
  • 4
  • Average True Range
  • 11.94
  • EPS
  • 6.96
  • Dividend Yield
  • 0
  • MACD Signal
  • 7.13
  • RSI
  • 54.67
  • MFI
  • 64.14

Latest Stock News Updates

Saakshi Medtech shares make stellar debut, stock lists at 50.5% premium at 146 on NSE SME

Saakshi Medtech shares make stellar debut on NSE SME, listed at 146 per share, 50.5% higher than issue price of 97.

Saakshi Medtech & Panels Financials

Saakshi Medtech & Panels Technicals

EMA & SMA

Current Price
₹236.00
-0.2 (-0.08%)
pointer
  • Bearish Moving Average 1
  • Bullish Moving Average 15
  • 20 Day
  • ₹232.98
  • 50 Day
  • ₹219.23
  • 100 Day
  • ₹205.56
  • 200 Day
  • ₹194.94

Resistance and Support

237.33 Pivot Speed
  • R3 257.67
  • R2 251.33
  • R1 243.67
  • S1 229.67
  • S2 223.33
  • S3 215.67

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Saakshi Medtech And Panels Ltd has an operating revenue of Rs. 281.82 Cr. on a trailing 12-month basis. An annual revenue growth of 25% is outstanding, Pre-tax margin of 14% is healthy, ROE of 11% is good. The company has a reasonable debt to equity of 15%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 11% and 26% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 8% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 81 which is a GOOD score indicating consistency in earnings, a RS Rating of 90 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 63 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock has great fundamentals and technical strength to stay in momentum.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Saakshi Medtech & Panels Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-26 Audited Results
2026-05-07 To consider Fund Raising
2025-11-14 Quarterly Results
2024-11-13 Quarterly Results
2024-05-28 Audited Results

Saakshi Medtech & Panels Shareholding Pattern

74.82%
0.07%
21.17%
3.94%

Saakshi Medtech & Panels FAQs

Saakshi Medtech & Panels share price is ₹236 As on 02 June, 2026 | 07:34

The Market Cap of Saakshi Medtech & Panels is ₹416.7 Cr As on 02 June, 2026 | 07:34

The P/E ratio of Saakshi Medtech & Panels is 33.9 As on 02 June, 2026 | 07:34

The PB ratio of Saakshi Medtech & Panels is 4 As on 02 June, 2026 | 07:34

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23